Cerecor (NASDAQ:CERC) will release its earnings data on Monday, March 12th.

Shares of Cerecor (NASDAQ CERC) opened at $4.93 on Monday. The company has a market capitalization of $128.45 and a P/E ratio of 13.32. Cerecor has a 1-year low of $0.34 and a 1-year high of $5.74.

Several research firms have recently commented on CERC. ValuEngine upgraded Cerecor from a “sell” rating to a “hold” rating in a report on Friday, December 1st. TheStreet upgraded Cerecor from an “e+” rating to a “c-” rating in a report on Wednesday, November 8th.

TRADEMARK VIOLATION NOTICE: This article was originally posted by Watch List News and is the property of of Watch List News. If you are reading this article on another domain, it was stolen and republished in violation of United States and international copyright and trademark law. The original version of this article can be read at https://www.watchlistnews.com/cerecor-cerc-scheduled-to-post-quarterly-earnings-on-monday/1908076.html.

Cerecor Company Profile

Cerecor, Inc is a clinical stage biopharmaceutical company. The Company is engaged in developing drug candidates for patients with neurological and psychiatric disorders. The Company has a portfolio of clinical and preclinical compounds that it is developing for a range of indications, including CERC-301, which is an adjunctive treatment for major depressive disorder (MDD); CERC-501, which is for substance use disorders and adjunctive treatment of MDD, and CERC-406, which is for the treatment of cognitive impairment.

Earnings History for Cerecor (NASDAQ:CERC)

Receive News & Ratings for Cerecor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerecor and related companies with MarketBeat.com's FREE daily email newsletter.